(Q38926686)

7 September 2017

MicroRNA-134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins (English)

1 reference

7 September 2017

1 reference

neoplastic stem cells

1 reference

1 reference

Yongtao Gao

1

1 reference

7 September 2017

Te Liu

series ordinal

2

1 reference

7 September 2017

Yongyi Huang

series ordinal

3

1 reference

7 September 2017

language of work or name

English

0 references

publication date

17 December 2014

1 reference

7 September 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

FEBS Letters

1 reference

7 September 2017

589

1 reference

7 September 2017

2

1 reference

7 September 2017

207-214

1 reference

Promising novel therapies for the treatment of endometrial cancer

7 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.12.002

MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.12.002

A microRNA-operated switch of asymmetric-to-symmetric cancer stem cell divisions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.12.002

MicroRNAs in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.12.002

MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.12.002

MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.12.002

Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.12.002

Emerging therapeutic biomarkers in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.12.002

The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.12.002

The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.12.002

Differential regulation of imprinting in the murine embryo and placenta by the Dlk1-Dio3 imprinting control region

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.12.002

DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.12.002

Hepatocyte nuclear factor-4α reverses malignancy of hepatocellular carcinoma through regulating miR-134 in the DLK1-DIO3 region

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.12.002

MicroRNAs in the imprinted DLK1-DIO3 region repress the epithelial-to-mesenchymal transition by targeting the TWIST1 protein signaling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.12.002

hCLP46 regulates U937 cell proliferation via Notch signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.12.002

Overexpression of hCLP46 enhances Notch activation and regulates cell proliferation in a cell type-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.12.002

Role of glycans and glycosyltransferases in the regulation of Notch signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.12.002

Rumi is a CAP10 domain glycosyltransferase that modifies Notch and is required for Notch signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.12.002

Notch signaling: the core pathway and its posttranslational regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.12.002

Mammalian Notch1 is modified with two unusual forms of O-linked glycosylation found on epidermal growth factor-like modules

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.12.002

Roles of Pofut1 and O-fucose in mammalian Notch signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.12.002

MicroRNA-122 influences the development of sperm abnormalities from human induced pluripotent stem cells by regulating TNP2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.12.002

Genome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin β1 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.12.002

miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.12.002

10.1016/J.FEBSLET.2014.12.002

21 January 2018

Identifiers

DOI

1 reference

7 September 2017

1 reference